메뉴 건너뛰기




Volumn 29, Issue 6, 2013, Pages 550-555

Intravitreal bevacizumab (Avastin) and panretinal photocoagulation in the treatment of high-risk proliferative diabetic retinopathy

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; BEVACIZUMAB; CORTICOSTEROID;

EID: 84880201329     PISSN: 10807683     EISSN: 15577732     Source Type: Journal    
DOI: 10.1089/jop.2012.0202     Document Type: Article
Times cited : (42)

References (23)
  • 1
    • 0027073276 scopus 로고
    • Retinopathy in a population-based study
    • Klein, R. Retinopathy in a population-based study. Trans. Am. Ophthalmol. Soc. 90:561-594, 1992
    • (1992) Trans. Am. Ophthalmol. Soc. , vol.90 , pp. 561-594
    • Klein, R.1
  • 2
    • 84880235572 scopus 로고    scopus 로고
    • Major clinical trials of vitreoretinal diseases
    • Regillo, C.D., Brown, G.C., Flyn, H.W., eds. New York: Theme Medical Publishers, Inc.;
    • Chew, E.Y. Major clinical trials of vitreoretinal diseases. In: Regillo, C.D., Brown, G.C., Flyn, H.W., eds. Vitreoretinal Disease, the Essentials. New York: Theme Medical Publishers, Inc.; 1999; p. 667-677.
    • (1999) Vitreoretinal Disease, the Essentials , pp. 667-677
    • Chew, E.Y.1
  • 3
    • 0025760218 scopus 로고
    • Fundus photographic risk factors for progression of diabetic retinopathy
    • Early Treatment Diabetic Retinopathy Study Research Group
    • Early Treatment Diabetic Retinopathy Study Research Group. Fundus photographic risk factors for progression of diabetic retinopathy. ETDRS Report No. 12. Ophthalmology. 98:823-833,1991
    • (1991) ETDRS Report No. 12. Ophthalmology. , vol.98 , pp. 823-833
  • 4
    • 0028123090 scopus 로고
    • Increased vascular endothelial growth factor levels in the vitreous of eyes with proliferative diabetic retinopathy
    • Adamis, A.P., Miller, J.W., Bernal, M.T., et al. Increased vascular endothelial growth factor levels in the vitreous of eyes with proliferative diabetic retinopathy. Am. J. Ophthalmol. 118:445-450, 1994
    • (1994) Am. J. Ophthalmol. , vol.118 , pp. 445-450
    • Adamis, A.P.1    Miller, J.W.2    Bernal, M.T.3
  • 5
    • 0027942607 scopus 로고
    • Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders
    • Aiello, L.P., Avery, R.L., Arrigg, P.G, et al. Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. N. Engl. J. Med. 331:1480-1487, 1994
    • (1994) N. Engl. J. Med. , vol.331 , pp. 1480-1487
    • Aiello, L.P.1    Avery, R.L.2    Arrigg, P.G.3
  • 6
    • 0029018364 scopus 로고
    • Hypoxia-induced expression of vascular endothelial growth factor by retinal cells is a common factor in neovascularizing ocular diseases
    • Pe'er, J., Shweiki D., Itin, A., et al. Hypoxia-induced expression of vascular endothelial growth factor by retinal cells is a common factor in neovascularizing ocular diseases. Lab. Invest. 72:638-645, 1995
    • (1995) Lab. Invest. , vol.72 , pp. 638-645
    • Pe'Er, J.1    Shweiki, D.2    Itin, A.3
  • 7
    • 23744502535 scopus 로고    scopus 로고
    • Pathogenesis of macular edema with branch retinal vein occlusion and intraocular levels of vascular endothelial growth factor and interleukin-6
    • Noma, H., Funatsu, H., Yamasaki, M., et al. Pathogenesis of macular edema with branch retinal vein occlusion and intraocular levels of vascular endothelial growth factor and interleukin-6. Am. J. Ophthalmol. 140:256-261, 2005
    • (2005) Am. J. Ophthalmol. , vol.140 , pp. 256-261
    • Noma, H.1    Funatsu, H.2    Yamasaki, M.3
  • 8
    • 27744514210 scopus 로고    scopus 로고
    • Elevated plasma CD105 and vitreous VEGF levels in diabetic retinopathy
    • Malik, R.A., Li, C., Aziz, W., et al. Elevated plasma CD105 and vitreous VEGF levels in diabetic retinopathy. J. Cell. Mol. Med. 9:692-697, 2005
    • (2005) J. Cell. Mol. Med. , vol.9 , pp. 692-697
    • Malik, R.A.1    Li, C.2    Aziz, W.3
  • 9
    • 33646440660 scopus 로고    scopus 로고
    • Testing intravitreal toxicity of bevacizumab (Avastin)
    • Manzano, R.P.A., Peyman, G.A., Khan, P., et al. Testing intravitreal toxicity of bevacizumab (Avastin). Retina. 26:257- 261, 2006
    • (2006) Retina. , vol.26 , pp. 257-261
    • Manzano, R.P.A.1    Peyman, G.A.2    Khan, P.3
  • 10
    • 33646464279 scopus 로고    scopus 로고
    • Intravitreal bevacizumab (Avastin) treatment of proliferative diabetic retinopathy complicated by vitreous hemorrhage
    • Spaide, R.F., and Fisher, Y.L. Intravitreal bevacizumab (Avastin) treatment of proliferative diabetic retinopathy complicated by vitreous hemorrhage. Retina. 26:275-278, 2006
    • (2006) Retina. , vol.26 , pp. 275-278
    • Spaide, R.F.1    Fisher, Y.L.2
  • 11
    • 33748982649 scopus 로고    scopus 로고
    • Intravitreal bevacizumab (Avastin) in the treatment of proliferative diabetic retinopathy
    • Avery, R.L., Pearlsman, J., Pieramici, D.J., et al. Intravitreal bevacizumab (Avastin) in the treatment of proliferative diabetic retinopathy. Ophthalmology. 113:1695-1705, 2006
    • (2006) Ophthalmology. , vol.113 , pp. 1695-1705
    • Avery, R.L.1    Pearlsman, J.2    Pieramici, D.J.3
  • 12
    • 33749631288 scopus 로고    scopus 로고
    • Intravitreal bevacizumab (Avastin) for persistent new vessels in diabetic retinopathy (IBEPE Study)
    • Jorge, R., Costa, R.A., Calucci, D., et al. Intravitreal bevacizumab (Avastin) for persistent new vessels in diabetic retinopathy (IBEPE Study). Retina. 26:1006-1013, 2006
    • (2006) Retina. , vol.26 , pp. 1006-1013
    • Jorge, R.1    Costa, R.A.2    Calucci, D.3
  • 13
    • 0018372140 scopus 로고
    • The third report from the Diabetic Retinopathy Study
    • Diabetic Retinopathy Study Research Group Four risk factors for severe visual loss in diabetic retinopathy
    • Diabetic Retinopathy Study Research Group. Four risk factors for severe visual loss in diabetic retinopathy. The third report from the Diabetic Retinopathy Study. Arch. Ophthalmol. 97:654-655, 1979
    • (1979) Arch. Ophthalmol. , vol.97 , pp. 654-655
  • 14
    • 0029803087 scopus 로고    scopus 로고
    • Intravitreous injections of vascular endothelial growth factor produce retinal ischemia and microangiopathy in an adult primate
    • Tolentino, M.J., Miller, J.W., Gragoudas, E.S., et al. Intravitreous injections of vascular endothelial growth factor produce retinal ischemia and microangiopathy in an adult primate. Ophthalmology. 103:1820-1828, 1996
    • (1996) Ophthalmology. , vol.103 , pp. 1820-1828
    • Tolentino, M.J.1    Miller, J.W.2    Gragoudas, E.S.3
  • 15
    • 0025892104 scopus 로고
    • Early photocoagulation for diabetic retinopathy. ETDRS report number 9
    • Early Treatment Diabetic Retinopathy Study Research Group
    • Early Treatment Diabetic Retinopathy Study Research Group. Early photocoagulation for diabetic retinopathy. ETDRS report number 9. Ophthalmology. 98:766-785, 1991
    • (1991) Ophthalmology. , vol.98 , pp. 766-785
  • 16
    • 0026328280 scopus 로고
    • Longterm stability and visual out-come after favourable initial response of proliferative diabetic retinopathy to panretinal photocoagulation
    • Vander, J.F., Duker, J.S., Benson, W.E., et al. Longterm stability and visual out-come after favourable initial response of proliferative diabetic retinopathy to panretinal photocoagulation. Ophthalmology. 98:1575-1579, 1991
    • (1991) Ophthalmology. , vol.98 , pp. 1575-1579
    • Vander, J.F.1    Duker, J.S.2    Benson, W.E.3
  • 17
    • 0026759362 scopus 로고
    • Pars plana vitrectomy in the Early Treatment Diabetic Retinopathy Study.
    • Flynn, H.W., Jr, Chew, E.Y., Simons, B.D., et al. Pars plana vitrectomy in the Early Treatment Diabetic Retinopathy Study. ETDRS Report No. 17. Ophthalmology. 99:1351-1357, 1992
    • (1992) ETDRS Report No. 17. Ophthalmology. , vol.99 , pp. 1351-1357
    • Flynn, H.W.1    Chew, E.Y.2    Simons, B.D.3
  • 18
    • 0019980977 scopus 로고
    • Single vsmultiple treatment sessions of argon laser panretinal photocoagulation for proliferative diabetic retinopathy
    • Doft, B.H., and Blankenship,G.W. Single vsmultiple treatment sessions of argon laser panretinal photocoagulation for proliferative diabetic retinopathy. Ophthalmology. 89:772-779, 1982
    • (1982) Ophthalmology. , vol.89 , pp. 772-779
    • Doft, B.H.1    Blankenshipg, W.2
  • 19
    • 34247231572 scopus 로고    scopus 로고
    • Rebound macular edema following bevacizumab (Avastin) therapy for retinal venous occlusive disease
    • Matsumoto, Y., Freund, K.B., Peiretti, E., et al. Rebound macular edema following bevacizumab (Avastin) therapy for retinal venous occlusive disease. Retina. 27:426-431, 2007
    • (2007) Retina. , vol.27 , pp. 426-431
    • Matsumoto, Y.1    Freund, K.B.2    Peiretti, E.3
  • 20
    • 58249094954 scopus 로고    scopus 로고
    • Intravitreal bevacizumab (Avastin) for proliferative diabetic retinopathy: 6-months follow-up
    • Arevalo, J.F., Wu, L., Sanchez, J.G., et al. Intravitreal bevacizumab (Avastin) for proliferative diabetic retinopathy: 6-months follow-up. Eye. 23:117-123, 2009
    • (2009) Eye. , vol.23 , pp. 117-123
    • Arevalo, J.F.1    Wu, L.2    Sanchez, J.G.3
  • 21
    • 42449094689 scopus 로고    scopus 로고
    • Comparison of two doses of intravitreal bevacizumab (Avastin) for treatment of macular edema secondary to branch retinal vein occlusion: Results from the Pan-American Collaborative Retina Study Group at 6 months of follow-up
    • Wu, L., Arevalo, J.F., Roca, J.A., et al. Comparison of two doses of intravitreal bevacizumab (Avastin) for treatment of macular edema secondary to branch retinal vein occlusion: results from the Pan-American Collaborative Retina Study Group at 6 months of follow-up. Retina. 28:212-219, 2008
    • (2008) Retina. , vol.28 , pp. 212-219
    • Wu, L.1    Arevalo, J.F.2    Roca, J.A.3
  • 22
    • 70349150585 scopus 로고    scopus 로고
    • Intravitreal bevacizumab and panretinal photocoagulation for proliferative diabetic retinopathy associated with vitreous hemorrhage
    • Huang, Y.H., Yeh, P.T., Chen, M.S., Yang, C.H., and Yang, C.M. Intravitreal bevacizumab and panretinal photocoagulation for proliferative diabetic retinopathy associated with vitreous hemorrhage. Retina. 29:1134-1140,2009
    • (2009) Retina. , vol.29 , pp. 1134-1140
    • Huang, Y.H.1    Yeh, P.T.2    Chen, M.S.3    Yang, C.H.4    Yang, C.M.5
  • 23
    • 38949099070 scopus 로고    scopus 로고
    • Tractional retinal detachment following intravitreal bevacizumab (Avastin) in patients with severe proliferative diabetic retinopathy
    • Arevalo, J.F., Maia, M., Flynn, H.W., Jr., et al. Tractional retinal detachment following intravitreal bevacizumab (Avastin) in patients with severe proliferative diabetic retinopathy. Br. J. Ophthalmol. 92:213-216,2008
    • (2008) Br. J. Ophthalmol. , vol.92 , pp. 213-216
    • Arevalo, J.F.1    Maia, M.2    Flynn Jr., H.W.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.